Cowealth Medical China Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-35.93	-33.64	27.57	47.19	82.72	80.23
Depreciation & Amortization	8.64	8.64	8.86	10.65	11.19	14.14
Other Amortization	19.52	19.52	10.07	7.11	11.93	7.77
Loss (Gain) From Sale of Assets	-0.05	-0.05	-0.44	-0.1	-0.2	0
Asset Writedown & Restructuring Costs	0.01	0.01	0.02	0.02	0.36	1.06
Loss (Gain) From Sale of Investments	-0.25	-0.25	-	-0.07	-0.64	-
Provision & Write-off of Bad Debts	12.7	12.7	-10.24	-2.88	2.47	3
Other Operating Activities	-89.18	3.82	8.67	6.99	4.8	-2.81
Change in Accounts Receivable	4.2	4.2	46.65	1.65	-234.74	-70.83
Change in Inventory	-10.67	-10.67	-12.06	7.44	-27.21	-39.57
Change in Accounts Payable	20.14	20.14	49.35	-64.21	121.67	10.33
Change in Other Net Operating Assets	-	-	-	-	-	0.32
Operating Cash Flow	-77.61	17.68	132.75	11.28	-30.37	7.01
Operating Cash Flow Growth	-	-86.68%	1076.77%	-	-	-90.55%
Capital Expenditures	-13.38	-14.21	-31.82	-67.96	-25.94	-22.12
Sale of Property, Plant & Equipment	0.15	0.16	0.8	0.12	0.47	0.03
Investment in Securities	-119.89	-129.83	-	11.18	-5.36	-
Other Investing Activities	108.42	2.72	2.13	5.01	4.92	4.67
Investing Cash Flow	-24.7	-141.16	-28.9	-51.65	-25.91	-17.43
Long-Term Debt Issued	-	126.97	529.67	715.34	309.72	429.21
Long-Term Debt Repaid	-	-116.16	-548.02	-726.43	-367.14	-431.08
Net Debt Issued (Repaid)	56.31	10.81	-18.36	-11.09	-57.42	-1.86
Issuance of Common Stock	-	-	-	-	380.6	-
Common Dividends Paid	-52.36	-52.66	-26.95	-65.25	-74.54	-79.65
Other Financing Activities	6.48	7.33	-0.17	-2.54	-22.92	-8.09
Financing Cash Flow	10.42	-34.52	-45.48	-78.87	225.73	-89.61
Foreign Exchange Rate Adjustments	-0.94	-0.91	0.25	-0.39	1.17	-2.44
Net Cash Flow	-92.83	-158.91	58.63	-119.63	170.62	-102.46
Free Cash Flow	-90.99	3.47	100.93	-56.68	-56.31	-15.11
Free Cash Flow Growth	-	-96.56%	-	-	-	-
Free Cash Flow Margin	-13.86%	0.51%	10.75%	-5.19%	-4.40%	-1.27%
Free Cash Flow Per Share	-0.20	0.01	0.26	-0.14	-0.15	-0.05
Cash Income Tax Paid	10.43	17	37.13	55.71	62.36	66.16
Levered Free Cash Flow	23.55	80.74	82.13	-73.65	-87.22	-113.8
Unlevered Free Cash Flow	25	82.18	84.21	-69.98	-84.57	-110.95
Change in Working Capital	6.94	6.94	88.24	-57.63	-143	-96.38

Updated Mar 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.